Dioleoyl-phosphatidic acid selectively binds to a-synuclein and strongly induces its aggregation

被引:34
作者
Mizuno, Satoru [1 ]
Sasai, Hirotaka [1 ]
Kume, Aiko [1 ]
Takahashi, Daisuke [1 ]
Satoh, Mamoru [2 ,3 ]
Kado, Sayaka [3 ]
Sakane, Fumio [1 ]
机构
[1] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan
[2] Chiba Univ Hosp, Div Clin Mass Spectrometry, Chiba, Japan
[3] Chiba Univ, Ctr Analyt Instrumentat, Chiba, Japan
基金
日本科学技术振兴机构;
关键词
aggregation; Parkinson's disease; phosphatidic acid; a-helix; a-synuclein; PROTEIN SECONDARY STRUCTURE; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; DIACYLGLYCEROL KINASES; MEMBRANE; RISK; BRAIN; PHOSPHOLIPIDS; ASSOCIATION; ACTIVATION;
D O I
10.1002/1873-3468.12592
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Synuclein (alpha-syn), which causally links to Parkinson's disease, binds to vesicles containing phosphatidic acid (PA). However, the effects of the fatty acyl chains of PA on its ability to bind to alpha-syn protein remain unclear. Intriguingly, we reveal that among several PA species, 18:1/18:1-PA is the most strongly bound PA to the alpha-syn protein. Moreover, 18:1/18:1-PA more strongly enhances secondary structural changes from the random coil form to the alpha-helical form than 16:0/18:1-PA. Furthermore, 18:1/18:1-PA more markedly accelerates generation of multimeric and proteinase K-resistant alpha-syn protein compared to 16:0/ 18:1-PA. These results indicate that among phospholipids examined so far, 18:1/18:1-PA demonstrates the strongest binding to alpha-syn, as well as the most effective enhancement of its secondary structural changes and aggregation formation.
引用
收藏
页码:784 / 791
页数:8
相关论文
共 42 条
[1]   Phospholipase D Signaling Pathways and Phosphatidic Acid as Therapeutic Targets in Cancer [J].
Bruntz, Ronald C. ;
Lindsley, Craig W. ;
Brown, H. Alex .
PHARMACOLOGICAL REVIEWS, 2014, 66 (04) :1033-1079
[2]   Effects of Parkinson's disease-linked mutations on the structure of lipid-associated α-synuclein [J].
Bussell, R ;
Eliezer, D .
BIOCHEMISTRY, 2004, 43 (16) :4810-4818
[3]   GAK rs1564282 and DGKQ rs11248060 increase the risk for Parkinson's disease in a Chinese population [J].
Chen, Yong Ping ;
Song, Wei ;
Huang, Rui ;
Chen, Ke ;
Zhao, Bi ;
Li, Jianpeng ;
Yang, Yuan ;
Shang, Hui-Fang .
JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (06) :880-883
[4]   Stabilization of α-synuclein secondary structure upon binding to synthetic membranes [J].
Davidson, WS ;
Jonas, A ;
Clayton, DF ;
George, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (16) :9443-9449
[5]   Phosphatidic acid-mediated mitogenic activation of mTOR signaling [J].
Fang, YM ;
Vilella-Bach, M ;
Bachmann, R ;
Flanigan, A ;
Chen, J .
SCIENCE, 2001, 294 (5548) :1942-1945
[6]   The phospholipase D superfamily as therapeutic targets [J].
Frohman, Michael A. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (03) :137-144
[7]  
Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/NCHEMBIO.1750, 10.1038/nchembio.1750]
[8]   Cell biology and pathophysiology of the diacylglycerol kinase family: Morphological aspects in tissues and organs [J].
Goto, Kaoru ;
Hozumi, Yasukazu ;
Nakano, Tornoyuki ;
Saino, Sachiko S. ;
Kondo, Hisatake .
SURVEY OF CELL BIOLOGY, 2007, 264 :25-+
[9]  
Houssa B, 1997, J BIOL CHEM, V272, P10422
[10]   Phosphatidic acid induces the differentiation of human acute promyelocytic leukemic cells into dendritic cell-like [J].
In, Jun-O ;
Park, Hae-Young ;
Kim, Ja-Woong ;
Park, Joo-In ;
Hong, Young-Seoub ;
Min, Do Sik ;
Kwak, Jong-Young .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 100 (01) :191-203